Literature DB >> 11427421

Cross-reactivity of Epstein-Barr virus-specific immunoglobulin M antibodies with cytomegalovirus antigens containing glycine homopolymers.

D Lang1, R Vornhagen, M Rothe, W Hinderer, H H Sonneborn, B Plachter.   

Abstract

Timely and reliable detection of acute primary human cytomegalovirus (HCMV) infection is important in prenatal screening programs and for differential diagnosis of infectious mononucleosis-like disease. Enzyme-linked immunosorbent assays (ELISAs) based on HCMV proteins enable the sensitive detection of immunoglobulin M (IgM) antibodies during primary infection. However, concerns have been raised about possible cross-reactivities of the HCMV antigens used for the design of such ELISAs with IgM antibodies induced by Epstein-Barr Virus (EBV). In this study we investigated whether IgM antibodies generated during acute EBV infection reacted with recombinant HCMV antigens. Serum samples from patients with primary EBV infection frequently scored positive when tested in different HCMV IgM ELISAs, irrespective of whether conventional or recombinant antigens were used for the design of the HCMV IgM assays. Such cross-reactive IgM antibodies were found to be directed against short glycine-rich motifs contained within the nonstructural HCMV proteins pUL44 and pUL57. Further analyses revealed that these glycine-rich motifs were major antigenic domains for IgM antibodies induced during HCMV infection. Their deletion from recombinant proteins abrogated reactivity with IgM synthesized during HCMV infection. EBV-induced IgM antibodies that reacted with HCMV antigens showed similar kinetics of reactivity in HCMV- or EBV-specific assays in the course of primary EBV infection, indicating that the two populations of antibodies were highly overlapping. The results demonstrate that primary EBV infection leads to the induction of IgM antibodies that specifically bind to widely used diagnostic antigens of HCMV. This has to be considered in the interpretation of HCMV-specific IgM assays.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11427421      PMCID: PMC96137          DOI: 10.1128/CDLI.8.4.747-756.2001

Source DB:  PubMed          Journal:  Clin Diagn Lab Immunol        ISSN: 1071-412X


  48 in total

1.  Immunoglobulin A-specific serodiagnosis of acute human cytomegalovirus infection by using recombinant viral antigens.

Authors:  R Vornhagen; W Hinderer; H H Sonneborn; G Bein; L Matter; T H The; G Jahn; B Plachter
Journal:  J Clin Microbiol       Date:  1996-04       Impact factor: 5.948

2.  Polymerase chain reaction to evaluate antiviral therapy for cytomegalovirus disease.

Authors:  H Einsele; G Ehninger; M Steidle; A Vallbracht; M Müller; H Schmidt; J G Saal; H D Waller; C A Müller
Journal:  Lancet       Date:  1991-11-09       Impact factor: 79.321

3.  Comparative immunoblot analysis with ten different, partially overlapping recombinant fusion proteins derived from five different cytomegalovirus proteins.

Authors:  J Van Zanten; T Lazzarotto; B Campisi; R Vornhagen; G Jahn; M P Landini; T H The
Journal:  New Microbiol       Date:  1995-04       Impact factor: 2.479

4.  Clinical significance of expression of human cytomegalovirus pp67 late transcript in heart, lung, and bone marrow transplant recipients as determined by nucleic acid sequence-based amplification.

Authors:  G Gerna; F Baldanti; J M Middeldorp; M Furione; M Zavattoni; D Lilleri; M G Revello
Journal:  J Clin Microbiol       Date:  1999-04       Impact factor: 5.948

5.  Localization and diagnostic application of immunodominant domains of the BFRF3-encoded Epstein-Barr virus capsid protein.

Authors:  W M van Grunsven; W J Spaan; J M Middeldorp
Journal:  J Infect Dis       Date:  1994-07       Impact factor: 5.226

6.  Antibodies to human cytomegalovirus structural polypeptides during primary infection.

Authors:  M P Landini; E Rossier; H Schmitz
Journal:  J Virol Methods       Date:  1988-12       Impact factor: 2.014

7.  Development of a new cytomegalovirus (CMV) immunoglobulin M (IgM) immunoblot for detection of CMV-specific IgM.

Authors:  T Lazzarotto; A Ripalti; G Bergamini; M C Battista; P Spezzacatena; F Campanini; P Pradelli; S Varani; L Gabrielli; G T Maine; M P Landini
Journal:  J Clin Microbiol       Date:  1998-11       Impact factor: 5.948

8.  Lack of correlation between virus detection and serologic tests for diagnosis of active cytomegalovirus infection in patients with AIDS.

Authors:  T Lazzarotto; P Dal Monte; M C Boccuni; A Ripalti; M P Landini
Journal:  J Clin Microbiol       Date:  1992-04       Impact factor: 5.948

9.  IgM-specific serodiagnosis of acute human cytomegalovirus infection using recombinant autologous fusion proteins.

Authors:  R Vornhagen; W Hinderer; H H Sonneborn; G Bein; L Matter; T H The; G Enders; G Jahn; B Plachter
Journal:  J Virol Methods       Date:  1996-06       Impact factor: 2.014

Review 10.  Quantitation of cytomegalovirus: methodologic aspects and clinical applications.

Authors:  M Boeckh; G Boivin
Journal:  Clin Microbiol Rev       Date:  1998-07       Impact factor: 26.132

View more
  10 in total

1.  False positive immunoglobulin m antibody to cytomegalovirus in child with infectious mononucleosis caused by epstein-barr virus infection.

Authors:  Jee Min Park; Jae Il Shin; Jae Seung Lee; Young Ho Jang; Sung Hun Kim; Kang Hyuk Lee; Chang Hoon Lee
Journal:  Yonsei Med J       Date:  2009-10-21       Impact factor: 2.759

2.  Clinical evaluation of new automated cytomegalovirus IgM and IgG assays for the Elecsys(®) analyser platform.

Authors:  M G Revello; C Vauloup-Fellous; L Grangeot-Keros; J van Helden; Y Dickstein; I Lipkin; A Mühlbacher; T Lazzarotto
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-08-01       Impact factor: 3.267

3.  Decreased HHV-6 IgG in Alzheimer's Disease.

Authors:  Gabriel Westman; Jonas Blomberg; Zhibing Yun; Lars Lannfelt; Martin Ingelsson; Britt-Marie Eriksson
Journal:  Front Neurol       Date:  2017-02-20       Impact factor: 4.003

Review 4.  Epstein-Barr Virus Epidemiology, Serology, and Genetic Variability of LMP-1 Oncogene Among Healthy Population: An Update.

Authors:  Maria K Smatti; Duaa W Al-Sadeq; Nadima H Ali; Gianfranco Pintus; Haissam Abou-Saleh; Gheyath K Nasrallah
Journal:  Front Oncol       Date:  2018-06-13       Impact factor: 6.244

5.  Diagnostic performance of cytomegalovirus (CMV) immune monitoring with ELISPOT and QuantiFERON-CMV assay in kidney transplantation: A PRISMA-compliant article.

Authors:  Yashi Ruan; Wei Guo; Sudong Liang; Zhen Xu; Tianli Niu
Journal:  Medicine (Baltimore)       Date:  2019-04       Impact factor: 1.817

6.  Impact of Epstein-Barr virus co-infection on natural acquired Plasmodium vivax antibody response.

Authors:  Michelle H F Dias; Luiz F F Guimarães; Matheus G Barcelos; Eduardo U M Moreira; Maria F A do Nascimento; Taís N de Souza; Camilla V Pires; Talita A F Monteiro; Jaap M Middeldorp; Irene S Soares; Cor J F Fontes; Francis B Ntumngia; John H Adams; Flora S Kano; Luzia H Carvalho
Journal:  PLoS Negl Trop Dis       Date:  2022-08-03

7.  Whole CMV proteome pattern recognition analysis after HSCT identifies unique epitope targets associated with the CMV status.

Authors:  Lena Pérez-Bercoff; Davide Valentini; Simani Gaseitsiwe; Shahnaz Mahdavifar; Mike Schutkowski; Thomas Poiret; Åsa Pérez-Bercoff; Per Ljungman; Markus J Maeurer
Journal:  PLoS One       Date:  2014-04-16       Impact factor: 3.240

8.  Infectious mononucleosis-like syndrome with high lymphocytosis and positive IgM EBV and CMV antibodies in a three-year-old girl.

Authors:  Joanna Alicja Krupka; Katarzyna Samelska; Anna Tomasik; Anna Stelmaszczyk-Emmel; Katarzyna Pawelec
Journal:  Cent Eur J Immunol       Date:  2017-08-08       Impact factor: 2.085

9.  Herpesvirus Infection Induces both Specific and Heterologous Antiviral Antibodies in Carp.

Authors:  Julio M Coll
Journal:  Front Immunol       Date:  2018-01-24       Impact factor: 7.561

10.  Coinfections and differential diagnosis in immunocompetent patients with uveitis of infectious origin.

Authors:  Alejandra de-la-Torre; Juanita Valdés-Camacho; Clara López de Mesa; Andrés Uauy-Nazal; Juan David Zuluaga; Lina María Ramírez-Páez; Felipe Durán; Elizabeth Torres-Morales; Jessica Triviño; Mateo Murillo; Alba Cristina Peñaranda; Juan Carlos Sepúlveda-Arias; Jorge Enrique Gómez-Marín
Journal:  BMC Infect Dis       Date:  2019-01-25       Impact factor: 3.090

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.